Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, has secured new financing of up to $57 million from Madryn Asset Management.

Bigfoot Biomedical was founded by a team of people with a personal connection to type 1 diabetes. With its Loop and Inject services, the company seeks to reduce the burden of living with insulin-requiring diabetes and to maximize the leverage of health care providers through data, connectivity, automation, and artificial intelligence.